₹30.97
■ +0 +0.00%
17 Jul 2026
BSE Listed
GSM 0 · ESM 1Rekvina Laboratories Ltd. (526075)
Volume: 2,205Avg Vol 1W: 646Avg Vol 1M: 1,02852W Range:₹6.75₹46.65
Key Ratios
Checked just nowMarket Cap₹19 Cr
Current Price₹30.97
Previous Close₹30.97
High / Low (52w)₹46.65 / ₹6.75
Volume2,205
Avg Vol (1W)646
Avg Vol (1M)1,028
Stock P/E—
Book Value₹-2.03
Dividend Yield0%
ROE20.74%
ROA-21.01%
Revenue (TTM)—
Revenue Growth—
Profit Margin-19.69%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0
P/B0
Debt / Equity0
50 DMA₹37.91
200 DMA—
Day change+0.00%
SurveillanceGSM 0 · ESM 1 (as of 2026-07-17)
Price Chart
₹30.97▲ 337.43% · 1Y
2026-01-132026-07-16
20-day avg volume: 1K shares
Pros
- Healthy return on equity of 20.7%.
- Company is almost debt-free.
Cons
- Company is loss-making at the latest annual result.
- Negative book value per share.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net Profit | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| EPS | -0.03 | -0.13 | 0 | -0.11 | -0.13 | -0 | -0.03 | -0.23 |
Balance Sheet
| Metric | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Total Liabilities | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Equity | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Financing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Free Cash Flow | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Shareholding
Promoter 41.3% Institutions 0% Public 58.7%
Efficiency & Working Capital
ROCE-104.2%
Interest Coverage0
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details
As of 2026-03-31
Promoter41.3%
FII0%
DII0%
Institutions0%
Public58.7%
Promoter Pledge0%
No. of Shareholders2,475
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 58.7% | 58.7% | 58.7% | 58.7% | 58.7% | 58.7% | 58.7% | 58.7% | 58.7% | 58.7% | 58.7% | 58.7% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 2,440 | 2,440 | 2,440 | 2,432 | 2,431 | 2,445 | 2,430 | 2,427 | 2,442 | 2,427 | 503 | 2,475 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Surbhit Mukesh Shah | Shareholding of Promoter and Promoter Group | 15.2% | 9,17,607 |
| Amit Mukesh Shah | Shareholding of Promoter and Promoter Group | 13.7% | 8,27,883 |
| Mukesh Jamnadas Shah | Shareholding of Promoter and Promoter Group | 12.3% | 7,43,993 |
| Niravbhai Jashubhai Patel | Public Shareholding | 6.5% | 3,89,921 |
| Dilsan Pharma Impex Private Limited | Public Shareholding | 6.4% | 3,85,773 |
| Abhijit Dharmeshbhai Mehta | Public Shareholding | 4.5% | 2,69,000 |
| Arunkumar Narsingh Rao | Public Shareholding | 3.9% | 2,37,000 |
| Kishorbhai J Suratwala | Public Shareholding | 3.8% | 2,29,694 |
| Khushali Nemish Badani | Public Shareholding | 2.4% | 1,44,175 |
| Amitkumar Arunkumar Rao | Public Shareholding | 1.7% | 99,531 |
| Nemishbhai Jayeshbhai Badani | Public Shareholding | 1.5% | 90,175 |
| Pareshkumar Rameshchandra Patel | Public Shareholding | 1.5% | 87,109 |
| Sanjay Bhanubhai Shah | Public Shareholding | 1.1% | 65,000 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Amit Mukesh Shah | 0 | 0% | 2026-03-31 |
| Surbhit Mukesh Shah | 0 | 0% | 2026-03-31 |
| Mukesh Jamnadas Shah | 0 | 0% | 2026-03-31 |
| Khushali Nemish Badani | 0 | 0% | 2026-03-31 |
| Nemishbhai Jayeshbhai Badani | 0 | 0% | 2026-03-31 |
| Amitkumar Arunkumar Rao | 0 | 0% | 2026-03-31 |
| Kishorbhai J Suratwala | 0 | 0% | 2026-03-31 |
| Arunkumar Narsingh Rao | 0 | 0% | 2026-03-31 |
| Pareshkumar Rameshchandra Patel | 0 | 0% | 2026-03-31 |
| Niravbhai Jashubhai Patel | 0 | 0% | 2026-03-31 |
| Sanjay Bhanubhai Shah | 0 | 0% | 2026-03-31 |
| Abhijit Dharmeshbhai Mehta | 0 | 0% | 2026-03-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| ILA RAJENDRA PATHAK | Chairman(Non Exe)&Dir(Non-Ind) | 2025 |
| Amit Mukeshbhai Shah | Managing Director | 2025 |
| Surbhit Shah | Executive Director & CFO | 2025 |
| Dhruval Patel | Independent Non Exe. Director | 2025 |
| Nilesh Harkesh Yadav | Independent Director | 2025 |
| Deepak Khandelwal | Company Sec. & Compli. Officer | 2025 |
| PRATEEK JAIN | Additional Director | 2025 |
| Jay Chintan Patel | Additional Director | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹5 | 4 | 3 | 3 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
Substantial Acquisitions (SAST)
1 disclosure(s)
Off Market15/05/2025 - 16/05/2025 · 1,13,245
Company Information
🌐 www.rekvinalaboratories.com ↗
📍 328 Paradise Complex, Sayajigunj, Vadodara, Gujarat, 390005
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search